Literature DB >> 3917455

Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia.

P Bouchard, M Lagoguey, S Brailly, G Schaison.   

Abstract

Hyperprolactinemia in men is frequently associated with hypogonadism. Normalization of serum PRL levels is generally associated with an increase in serum testosterone (T) to normal. To determine the mechanism of the inhibitory effect of hyperprolactinemia on the hypothalamic-pituitary-gonadal axis, we studied the effect of intermittent pulsatile GnRH administration on LH pulsatility and T levels in four men with prolactinomas. All patients had high PRL values (100-3000 ng/ml), low LH (mean +/- SEM, 2.2 +/- 0.1 mIU/ml), and low T values (2.3 +/- 0.3 ng/ml), with no other apparent abnormality of pituitary function. GnRH was administered iv using a pump delivering a bolus dose of 10 micrograms every 90 min for 12 days. No LH pulses were detected before treatment. Pulsatile GnRH administration resulted in a significant increase in basal LH levels (6.7 +/- 0.6 mIU/ml; P less than 0.001) and restored LH pulsatility. In addition, T levels increased significantly to normal values in all patients (7.8 +/- 0.4 ng/ml; P less than 0.001) and were normal or supranormal as long as the pump was in use, although PRL levels remained elevated. These data, therefore, suggest that hyperprolactinemia produces hypogonadism primarily by interfering with pulsatile GnRH release.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917455     DOI: 10.1210/jcem-60-2-258

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Pulsatile LHRH therapy for induction of ovulation in patients with hyperprolactinaemia and bromocriptine intolerance.

Authors:  J M Wilson; A B Atkinson; B Sheridan; A I Traub; J M Harley
Journal:  Ir J Med Sci       Date:  1987-08       Impact factor: 1.568

2.  Frequency of recovery from anorexia nervosa of a cohort patients re-evaluated on a long-term basis following intensive care.

Authors:  L Foppiani; L Luise; E Rasore; U Menichini; M Giusti
Journal:  Eat Weight Disord       Date:  1998-06       Impact factor: 4.652

3.  Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.

Authors:  Charlotte Sonigo; Justine Bouilly; Nadège Carré; Virginie Tolle; Alain Caraty; Javier Tello; Fabian-Jesus Simony-Conesa; Robert Millar; Jacques Young; Nadine Binart
Journal:  J Clin Invest       Date:  2012-09-24       Impact factor: 14.808

4.  Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea.

Authors:  Robert P Millar; Charlotte Sonigo; Richard A Anderson; Jyothis George; Luigi Maione; Sylvie Brailly-Tabard; Philippe Chanson; Nadine Binart; Jacques Young
Journal:  J Endocr Soc       Date:  2017-10-16

5.  Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.

Authors:  Haiyan Yang; Jie Lin; He Li; Zhangwei Liu; Xia Chen; Qianqian Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.